Wednesday Sep 3
Nuvo ResearchA Completes Enrolment in WF10a Phase 2 Clinical Trial
The Company expects the trial to be completed in late 2014 with top-line results anticipated in the first quarter of 2015.
Medical News Today
ALK presents Phase III data on house dust mite SLIT-tablet
ALK has presented key trial results on its new sublingual allergy immunotherapy tablet for house dust mite respiratory allergic diseases at the 2014 Annual Congress of the European Academy of Allergy and Clinical Immunology , in Copenhagen, Denmark.
How Stuff Works
Do allergies cause nasal congestion?
Allergies can result in a number of symptoms, whose severity can vary from person to person.